Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

Open Access 23-12-2022 | Original Paper

Retinal Thinning in Adults with Autism Spectrum Disorder

Auteurs: Evelyn B. N. Friedel, Ludger Tebartz van Elst, Mirjam Schäfer, Simon Maier, Kimon Runge, Sebastian Küchlin, Michael Reich, Wolf A. Lagrèze, Jürgen Kornmeier, Dieter Ebert, Dominique Endres, Katharina Domschke, Kathrin Nickel

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2024

Abstract

Since the retina shares its embryological origin with the central nervous system, optical coherence tomography (OCT), an imaging technique frequently employed in ophthalmology to analyze the macula and intraretinal layer thicknesses and volumes, has recently become increasingly important in psychiatric research. We examined 34 autistic and 31 neurotypical adults (NT) using OCT. Autistic adults had reduced overall macular and outer nuclear layer (ONL) thickness and volume compared to NT. Both macular and ONL thickness showed significant inverse associations with the severity of autistic symptoms measured with the Social Responsiveness Scale 2 (SRS-2). Longitudinal studies across different age groups are required to clarify whether retinal changes may represent a possible trait marker.

Supplementary file1 (DOCX 21 kb)

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s10803-022-05882-8.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Autism spectrum disorders (ASD) are characterized by difficulties in social interaction and communication as well as stereotypical behaviors including hypo- and/or hypersensitivity to sensory stimuli (American Psychiatric Association, 2013; Tebartz van Elst, 2021). The underlying etiology is still unknown, with a strong genetic component, environmental and neurobiological factors as well as brain developmental alterations appearing to be involved (Lord et al., 2018; Pardo & Eberhart, 2007). Neuroimaging studies in ASD point towards an altered trajectory of brain maturation with an overgrowth of brain volume in infancy and early childhood followed by a normalization in later childhood and adolescence (Courchesne et al., 2011; Ecker et al., 2015; Prigge et al., 2021). Hox genes are important in the molecular control of early morphogenesis (Gokhale & Gokhale, 2007) and were suggested to be involved in the central nervous system (CNS) development with the HOXA1 A218G polymorphism being associated with an enlarged cranial circumference in autism (Conciatori et al., 2004; Hashem et al., 2020). The retina and optic nerve share their neuroectodermal embryological origin with the brain, and are regarded as part of the CNS (Chua et al., 2021; Nguyen et al., 2017). Moreover, the thickness and volume of the intraretinal layers were found to be associated with total brain, gray and white matter volume (Chua et al., 2021; Mauschitz et al., 2022). Therefore, optical coherence tomography (OCT) as a non-invasive in vivo ophthalmologic routine examination method (Huang et al., 1991) is considered an innovative tool to investigate potential retinal alterations in autistic adults (Little, 2018; Nguyen et al., 2017; Silverstein et al., 2020) and can be regarded as a “window to the brain” (Schönfeldt-Lecuona et al., 2015).

OCT is a high-resolution imaging technique that relies on interference between the signal of an examined object and a local reference signal (Podoleanu, 2012) providing high-resolution cross-sectional images of the retina (Bagci et al., 2008). OCT has gained increasing importance in the examination of neurological disorders such as multiple sclerosis (Noval et al., 2011), Parkinson's and Alzheimer’s disease (Chan et al., 2019; Jindahra et al., 2010). In Alzheimer’s disease, for example, a thinner retinal nerve fiber layer (RNFL) was associated with an increased risk of dementia (Mutlu et al., 2018) and discussed as a possible correlate which might provide information on neurodegeneration of the brain (Mutlu et al., 2017). Therefore, OCT has also become a focus of psychiatric research, particularly in the investigation of patients with schizophrenia (Nguyen et al., 2017; Silverstein et al., 2020).

Studies investigating autistic adults applying OCT, however, are rare. Emberti Gialloreti et al. (2014) performed OCT examinations in 24 adults with ASD (11 with high functioning autism (HFA), 13 with Asperger Syndrome (AS)) compared to 24 neurotypical adults (NT). Autistic adults showed reduced thickness of the nasal peripapillary retinal nerve fiber layer (pRNFL) compared to NT. When dividing the ASD group into HFA and AS subsamples, the HFA group exhibited reduced global pRNFL thickness as well as nasal and inferior pRNFL thinning compared to NT, while the AS group showed only reduced nasal pRNFL thickness compared to NT. In contrast, García-Medina et al. (2017) reported a significantly thicker total retina (sum of all layers from the RNFL to the photoreceptors (PR)) and total inner retina (sum of all layers from the RNFL to the inner nuclear layer (INL)) at the fovea, as well as a significantly increased inferior pRNFL thickness in 27 children and young adolescents with high-functioning ASD compared to 27 NT. Additionally, they described a trend level elevated inner plexiform layer (IPL) and INL thickness at the fovea and trends of a thicker mean macular thickness (mean thickness of all 9 Early Treatment Diabetic Retinopathy Study (ETDRS) sectors) of the total and inner retina for the autistic adults (García-Medina et al., 2017). They suggested that the increased retinal thickness in ASD might result from parenchyma overgrowth (Bigler et al., 2010) or be related to neuroinflammatory processes such as microglia activation (García-Medina et al., 2017; Nakagawa & Chiba, 2016). Additionally, a positive association between the inferior pRNFL thickness and the composite intelligence quotient (IQ) was detected (García-Medina et al., 2017). A recent study (Garcia-Medina et al., 2020) reported higher optic nerve head (ONH) perfusion density and lower ONH flux at the peripapillary inferior quadrant in 13 autistic adolescents and young adults compared to NT, while the increase in the mean macular and inferior pRNFL thickness in autistic participants remained on trend level.

Aims of the Study

The objective of the study was to obtain detailed insight into possible structural retinal alterations in autistic adults compared to NT. Based on previous studies, we expected an atypical formation of the pRNFL. Due to inconclusive results of preceding investigations, we wanted to clarify whether the pRNFL is thicker, thinner, or unaltered in autistic adults compared to NT. Moreover, we aimed to compare the structural features of the circumfoveal intraretinal layers (RNFL, ganglion cell layer (GCL), IPL, INL, outer plexiform layer (OPL), outer nuclear layer (ONL), photoreceptor-retinal pigment epithelium (PR + RPE) complex) as well as the overall macular thickness (MT) and volume (MV) between autistic and neurotypical adults. Additionally, we aimed at determining whether there is an association between retinal alterations and the severity of autistic symptoms.

Methods

Participants

The study was approved by the local Ethics Committee (Approval ID: 314/18) and conducted in accordance with the Declaration of Helsinki (World Medical Association, 2013).

Thirty-four autistic adults with a diagnosis of Asperger Syndrome according to the 10^th revision of the International Classification of Diseases (ICD-10: F84.5) or autism spectrum disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) criteria were included in the study. The diagnosis was established by experienced specialists in psychiatry and psychotherapy with expertise in the diagnosis of ASD. The diagnostic assessment included the autism spectrum quotient (AQ) (Baron-Cohen et al., 2001), the empathy quotient (EQ) (Baron-Cohen & Wheelwright, 2004) and the Social Responsiveness Scale 2 (SRS-2) (Constantino, 2012), the Beck Depression Inventory (BDI-II) (Beck et al., 1996; Hautzinger et al., 2006) to evaluate comorbid depressive symptoms, the Wender Utah Rating Scale (WURS-k) (Retz-Junginger et al., 2002) for the investigation of comorbid symptoms of attention-deficit/hyperactivity disorder (ADHD) in childhood as well as the Multiple Choice Vocabulary Test (MWT-B) (Lehrl et al., 1995) as measure for crystallized intelligence. The autistic adults overlap with participants who have already been assessed for functional retinal changes using the electroretinogram (ERG) (Friedel et al., 2022b).

Thirty-one NT matched according to sex and age were additionally enrolled in the study. The NT participants had to be without a current or past history of a psychiatric illness. The following questionnaires were collected: the Structured Clinical Interview SCID-I (Wittchen et al., 1997) to rule out axis I psychiatric diseases according to DSM-IV criteria, the SCID-II (Fydrich et al., 1997) to additionally rule out axis II personality disorders, the AQ (Baron-Cohen et al., 2001), EQ (Baron-Cohen & Wheelwright, 2004) and SRS-2 (Constantino, 2012) questionnaire to rule out symptoms of an ASD, the BDI-II (Beck et al., 1996; Hautzinger et al., 2006) questionnaire to exclude a current depressive episode, the WURS-k (Retz-Junginger et al., 2002) to rule out ADHD symptoms in childhood as well as the Symptom Check List-90 (SCL-90) (Derogatis & Savitz, 1999) questionnaire. Moreover, the NT participants completed the MWT-B (Lehrl et al., 1995) questionnaire to assess the IQ.

The following exclusion criteria were defined for all study participants: ophthalmological diseases (with the exception of correctable refraction errors), low visual acuity (< 0.7 decimal visual acuity; measured with the Freiburg Acuity and Contrast Test (Bach, 2007)), myopia lower than − 6 dpt or hyperopia greater than + 6 dpt (Cruz-Herranz et al., 2016), ocular surgery, neurological disorders, diabetes mellitus or arterial hypertension, substance abuse, age < 18 years or > 65 years, bipolar disorder, psychotic symptoms, and insufficient collaboration during OCT imaging.

Optical Coherence Tomography (OCT)

Data acquisition, processing and reporting were performed in accordance with the “Advised Protocol for OCT Study Terminology and Elements” (APOSTEL) recommendations for OCT studies (Aytulun et al., 2021; Cruz-Herranz et al., 2016).

The SPECTRALIS® OCT (Heidelberg Engineering; mean wavelength of the superluminescent diode: 880 nm) with the Glaucoma Module Premium Edition® (version 6.9.4.0) and the Eye Explorer® software (version 1.10.2.0) were used for retinal imaging of both eyes of the participants. The sample rate for A-scans was 40 kHz in 3.9 µm/pixel depth resolution. Automated papillae and fovea detection were conducted using the implemented anatomic positioning system. The HRA/SPECTRALIS® module (version 6.9.5.0) was used for data export.

The “optic nerve head – radial circle scan” was used to measure the pRNFL thickness. During nasal fixation, 768 A- and 27 B-scans were acquired. Bruch’s membrane opening (BMO) was detected with 24 radial B-scans, 3 B-scans were circle scans with 3.5, 4.1, 4.7 mm diameter around the BMO center (15° scan angle) used for pRNFL evaluation. The global pRNFL thickness as well as the pRNFL thickness data for all tiles of the 6-sector Garway-Heath grid (Garway-Heath et al., 2000) were exported from the device (Fig. 1A).

Circumfoveal thickness and volume data of the macula and the intraretinal layers were obtained using the “posterior pole horizontal scan”. During central fixation, 768 A- and 61 B-scans were taken within a field of 30° × 25° (121 µm distance) around the foveal center (Fig. 1B). The total volume of the macula and all intraretinal layers as well as the thickness data for all tiles of the 9-sector ETDRS grid (Chew, 1996) were exported from the device.

Thickness data from the sectors were summarized into (a) total thickness of the ETDRS grid and (b) 3 foveal regions: fovea (C0; 1 mm), parafovea (S1, N1, I1, T1; 3 mm) and perifovea (S2, N2, I2, T2; 6 mm) (Fig. 1B).

All OCT images were individually checked for artifacts or incorrect layer segmentation and analyzed by an ophthalmologist for pathological findings before data extraction.

Statistical Analysis

Statistical analysis was performed in “R” (R Core Team, 2021) with RStudio (RStudio Team, 2022) using the “tidyverse”, “broom” and “purrr” packages for data handling (Henry & Wickham, 2020; Robinson et al., 2022; Wickham et al., 2019) and the “ggplot2” package (Wickham, 2016) for graphical representations. When available, data from both eyes were averaged for all participants. If one eye had to be excluded, only the other eye was considered in the analysis.

Since some of the partial datasets showed outliers and slight departures from the normal distribution, robust multiple linear regression models (function “lmrob”; package “robustbase” (Maechler et al., 2021)) were used to estimate differences in OCT measures between NT and autistic adults while controlling for age and sex. The regression formula was defined as:

$$\hat{Y} = \beta_{0} + \beta_{age} *age + \beta_{sex} *sex + \beta_{group} *group$$

The model was based on MM-type estimators (Koller & Stahel, 2011) to robustly predict the effect of group affiliation (β_group) on the OCT measures ($\widehat{Y}$) while controlling for age and sex as possible confounding variables. Age values were mean centred, and male NT were defined as reference (${\beta }_{0}$). The regression coefficients for group affiliation (β_group) thus directly indicate the robustly estimated differences of group means after adjusting for age and sex. Cohen’s d (Cohen, 1992) as effect size measure for group differences was calculated from the t-statistics of the corresponding group coefficients (“effectsize” package; (Ben-Shachar et al., 2020)). Cohen’s d >|0.2| was considered a small effect, d >|0.5| a moderate effect, and d >|0.8| a large effect.

Spearman correlation coefficients (Best & Roberts, 1975; Hollander & Wolfe, 1973) (rho; “rstatix” package (Kassambara, 2021)) were calculated for the autistic adults separately to evaluate associations between alterations in OCT measures and the severity of ASD-related symptoms, as classified by the psychometric instruments: AQ (Baron-Cohen et al., 2001), EQ (Baron-Cohen & Wheelwright, 2004) and SRS-2 (Constantino, 2012).

The significance level was defined as α = 0.05 and adjusted for multiple testing according to the Benjamini-Hochberg (1995) procedure, controlling the false discovery rate (FDR).

The total scores of the WURS-k (Retz-Junginger et al., 2002) and BDI-II (Beck et al., 1996; Hautzinger et al., 2006) were not included as covariates, because of a strong correlation with the predictor variable of group affiliation (no independence). However, to estimate if group differences between ASD and NT persist without possible confounding effects, we subsequently conducted explorative analyses on subsamples of autistic adults. We considered autistic adults (a) without elevated ADHD related symptoms in childhood (WURS-k < 30), (b) without elevated depressive symptoms (BDI-II < 14) and (c) without the intake of psychiatric medication and compared those separately to the NT group.

Results

Participants

Table 1 summarizes the demographic and psychometric data for ASD and NT. The mean age in both groups was 35 years (standard deviation: 10 years). Compared to NT, autistic adults showed increased depressiveness according to the BDI-II (Beck et al., 1996; Hautzinger et al., 2006) questionnaire and a higher level of ADHD symptoms in childhood as measured by the WURS-K (Retz-Junginger et al., 2002) questionnaire.

Table 1

Demographic and psychometric data

Parameter	Mean (SD) NT (N = 31)	Mean (SD) ASD (N = 34)	p-value
Sex (male/female)	19/12	21/13	> .999^#
Age in years	35 (10)	35 (10)	.963
IQ (MWT-B)	107 (11)	111 (16); Na = 1	.434
SRS-2	32 (13)	104 (27); Na = 2	< .001
AQ	12 (4)	34 (8); Na = 2	< .001
EQ	49 (11)	23 (12)	< .001
BDI-II	3 (3)	18 (13)	< .001
WURS-k	12 (9)	28 (15)	< .001
Psychiatric medication (yes/no)	0/31	20/14

Group comparisons based on Fishers-Exact- (#) and Wilcoxon-Tests

ASD autism spectrum disorder; AQ Autism Spectrum Quotient (Baron-Cohen et al., 2001); BDI-II Beck Depression Inventory II (Beck et al., 1996; Hautzinger et al., 2006); EQ Empathy quotient (Baron-Cohen & Wheelwright, 2004); N number; NT neurotypical adults; IQ intelligence quotient; MWT-B Multiple choice vocabulary test (Lehrl et al., 1995); SRS-2 Social Responsiveness Scale 2 (Constantino, 2012); SD standard deviation; WURS-k Wender Utah Rating Scale (Retz-Junginger et al., 2002)

Twenty autistic adults took psychiatric medication, while fourteen were unmedicated.

Fifteen took antidepressants (four selective serotonin reuptake inhibitors (SSRI), six serotonin and norepinephrine reuptake inhibitors (SNRI), two bupropion, three tetracyclic and four tricyclic antidepressants, one agomelatine), three methylphenidate, eight low dose atypical neuroleptics for stimulus shielding or as low dose sleeping pills, two mood stabilizers (one lithium, one lamotrigine) and one patient pregabalin.

Four right and five left eyes in the ASD group, as well as three right and three left eyes in the NT group had to be excluded due to low visual acuity (< 0.7 decimal visual acuity) or excessive refraction errors, coincidental pathological findings in the OCT images, inadequate cooperation or insufficient automated segmentation. Thus, 59 eyes from 34 autistic adults and 56 eyes from 31 NT could be included in the final analysis.

Peripapillary RNFL (pRNFL) Thickness (Optic Nerve Head – Radial Circle Scan)

The robust regression models for the globdal pRNFL thickness from the three circle scans revealed no significant differences in ASD compared to the NT group. However, the coefficients for sex (β_sex) indicated thicker global pRNFL for female participants in all three models (Table 2). Due to the lack of any group differences, no further post-hoc analyses for the pRNFL thickness data on sector level were performed.

Table 2

Arithmetic mean of the global pRNFL thickness and results from the robust regression models

Diameter	Mean (SD)		Results from the robust regression models
Diameter	NT	ASD	Parameter	Coefficients (β)	SE	p value	d
3.5 mm	102.52 (7.60)	101.43 (8.50)	Age	− 0.07	0.10	.454 (ns)	− 0.19
			Sex (female)	6.65	2.01	.002 (*)	0.86
			Group (ASD)	− 0.51	1.96	.794 (ns)	− 0.07
4.1 mm	87.98 (6.39)	86.7 (7.11)	Age	− 0.06	0.08	.469 (ns)	− 0.19
			Sex (female)	5.25	1.73	.004 (*)	0.78
			Group (ASD)	− 0.94	1.69	.581 (ns)	− 0.14
4.7 mm	76.98 (5.62)	76.17 (5.65)	Age	− 0.05	0.07	.511 (ns)	− 0.17
			Sex (female)	3.56	1.52	.022 (*)	0.61
			Group (ASD)	− 0.46	1.47	.755 (ns)	− 0.08

For both groups and all three scans, data were pooled over the 6 sector tiles of the Garway-Heath grid (Garway-Heath et al., 2000). Results of the robust regression analysis with the parameters coefficients (β), the corresponding standard errors (SE), p values, significance level in parentheses (*/ns) and effects sizes (d). Neurotypical males were considered as reference (β₀)

ASD autism spectrum disorder; d Cohen’s d; NT neurotypical adults; pRNFL peripapillary retinal nerve fiber layer; SD standard deviation; SE Standard error of the coefficients; significance level after Benjamini–Hochberg adjustment (Benjamini & Hochberg, 1995) in parentheses: * significant, ns not significant

Circumfoveal Retinal Layer Thicknesses and Volumes (Posterior Pole Horizontal Scan)

Total ETDRS Thickness and Volume of the Macula and the Intraretinal Layers

Figure 2A illustrates the total macular thickness (MT) and volume (MV) as well as the thickness and volume of all intraretinal layers (RNFL, GCL, IPL, INL, OPL, ONL, PR + RPE) for the ASD and NT group.

The regression models revealed a significant reduction in the total MT of autistic adults compared to NT (β_group = − 88 µm (2.99%); p = 0.003 (*); d = − 0.8), as well as in the MV (β_group = − 0.26 mm³ (2.89%); p = 0.005 (*); d = − 0.75). For the intraretinal layers, a significant reduction of the total ONL thickness (β_group = − 53.22 µm (7.75%); p = 0.002 (*); d = − 0.82) and ONL volume (β_group = − 0.15 mm³ (7.61%); p = 0.003 (*); d = − 0.78) were apparent for autistic adults compared to NT.

There was a reduction in the IPL and GCL thickness as well as in the GCL volume of autistic adults, which was not statistically significant after adjustment for multiple testing according to the Benjamini Hochberg procedure (1995). No group differences were found in the other retinal layers (Table 3).

Table 3

Mean (SD) thickness [µm] and volume [mm³] of the intraretinal layers and the MT and MV

Layer	Arithmetic mean (SD)		Results from the regression models
Layer	NT	SD	β_group	SE	p value	d
Total Volume [μm]
MT	2930.82 (111.29)	2850.29 (112.56)	− 88.00	28.34	.003 (*)	− 0.80
RNFL	244.97 (19.95)	238.99 (21.66)	− 5.46	5.26	.303 (ns)	− 0.27
GCL	385.42 (23.27)	370.09 (32.27)	− 15.04	7.14	.039 (ns)	− 0.54
IPL	322.36 (16.15)	312.35 (20.88)	− 10.78	4.79	.028 (ns)	− 0.58
INL	316.44 (16.96)	315.34 (23.07)	− 1.40	5.15	.787 (ns)	− 0.07
OPL	254.40 (17.06)	260.57 (20.25)	6.31	5.08	.219 (ns)	0.32
ONL	678.60 (64.26)	629.66 (63.02)	− 53.22	16.70	.002 (*)	− 0.82
PR + RPE	729.44 (20.00)	724.12 (18.74)	− 5.21	4.55	.257 (ns)	− 0.29
Total Volume [mm³]
MV	8.98 (0.35)	8.75 (0.34)	− 0.26	0.09	.005 (*)	− 0.75
RNFL	0.91 (0.09)	0.89 (0.09)	− 0.02	0.02	.318 (ns)	− 0.26
GCL	1.16 (0.06)	1.12 (0.09)	− 0.04	0.02	.030 (ns)	− 0.57
IPL	0.95 (0.04)	0.93 (0.06)	− 0.03	0.01	.047 (ns)	− 0.52
INL	0.98 (0.05)	0.98 (0.07)	0.00	0.01	.812 (ns)	− 0.06
OPL	0.78 (0.05)	0.79 (0.06)	0.01	0.01	.645 (ns)	0.12
ONL	1.95 (0.19)	1.81 (0.18)	− 0.15	0.05	.003 (*)	− 0.78
PR + RPE	2.25 (0.06)	2.24 (0.06)	− 0.01	0.01	.331 (ns)	− 0.25

Group coefficients (β_group), standard errors (SE), p values (significance level after Benjamini–Hochberg adjustment (Benjamini & Hochberg, 1995) in parentheses) and effects sizes (d) from the robust regression models are summarized. Significant differences are highlighted in bold. Male NT were defined as reference (β₀). Group coefficients (β_group) represent the robust estimated differences in means [µm/mm³] between NT and ASD after adjusting for age and sex

ASD autism spectrum disorder; β_group coefficient for the group parameter from the regression model; d Cohen’s d; GCL ganglion cell layer; INL inner nuclear layer; IPL inner plexiform layer; ns not significant; MT macular thickness; MV macular volume; NT neurotypical adults; ONL outer nuclear layer; OPL outer plexiform layer; RNFL retinal nerve fiber layer; PR + RPE photoreceptor-retinal pigment epithelium complex; SD standard deviation; SE standard error of the coefficient; * significant

Associations Between Retinal Thinning in Autistic Adults and the Severity of ASD Symptoms

Possible associations between the retinal thinning of the MT, MV and ONL thickness and volume with the severity of ASD symptoms (AQ, EQ, SRS-2) (Baron-Cohen & Wheelwright, 2004; Baron-Cohen et al., 2001; Constantino, 2012) were analyzed calculating Spearman correlation coefficients (rho). The significance level was adjusted for the number of tests.

Neither the AQ (Baron-Cohen et al., 2001), nor the EQ (Baron-Cohen & Wheelwright, 2004) scores showed statistically significant correlations with the thickness and volume of the macula and ONL. Significant inverse correlations were found for the total SRS-2 (Constantino, 2012) scores and the MT (rho = − 0.56; p < 0.001 (*)), the ONL thickness (rho = − 0.47; p = 0.007 (*)) and ONL volume (rho = − 0.47; p = 0.006 (*)) (Fig. 2B). The correlation between the SRS-2 score and the MV fell below the threshold for statistical significance after adjustment for multiple testing (rho = − 0.39; p = 0.027 (ns)).

Subsamples of Autistic Adults Without Comorbid (ADHD Symptoms in Childhood or Depressive) Symptoms or the Intake of Medication

In order to evaluate whether the reduction of the MT, MV and ONL thickness and volume in autistic adults persists independently of comorbid symptoms (ADHD in childhood, depression) or the intake of psychiatric medication, exploratory analyses of subsamples with ASD were conducted (Table 4). The statistically significant reduction in the MT and ONL thickness and volume was also apparent in the ASD subsample without elevated ADHD related symptoms in childhood (N = 19). The MV reduction, however, was no longer significant when compared to NT.

Table 4

Exploratory analysis on ASD subsamples without elevated comorbid symptoms or the intake of psychiatric medication

Subsample ASD	Layer & Measure	Results from the regression models comparing ASD subsamples to NT				Correlation with SRS-2 (ASD only)
Subsample ASD	Layer & Measure	β_group	SE	p value	d	rho	p value
ASD without ADHD symptoms (WURS-k < 30); N = 19	MT [µm]	− 70.65	33.85	.042	− 0.62	− 0.59	.015
	ONL thickness [µm]	− 45.34	20.29	.030	− 0.66	− 0.64	.007
	MV [mm³]	− 0.20	0.11	.080	− 0.53	− 0.39	.126
	ONL volume [mm³]	− 0.13	0.06	.041	− 0.62	− 0.62	.008
ASD without depressive symptoms (BDI-II < 14); N = 18	MT [µm]	− 95.74	30.53	.003	− 0.94	− 0.70	.002
	ONL thickness [µm]	− 41.54	19.76	.041	− 0.63	− 0.56	.020
	MV [mm³]	− 0.31	0.10	.003	− 0.93	− 0.58	.015
	ONL volume [mm³]	− 0.12	0.06	.051	− 0.60	− 0.52	.033
ASD without psychiatric medication; N = 14	MT [µm]	− 118.21	36.03	.002	− 1.02	− 0.68	.010
	ONL thickness [µm]	− 58.37	21.38	.009	− 0.85	− 0.87	< .001
	MV [mm³]	− 0.33	0.12	.008	− 0.87	− 0.60	.030
	ONL volume [mm³]	− 0.17	0.07	.012	− 0.83	− 0.90	< .001

Results from the exploratory regression models for group comparisons: group coefficients (β_group), standard error (SE), p values and effect sizes (d), with male neurotypical adults as reference (β₀). Results from the exploratory correlation analysis for the ASD subsamples: spearman’s rho and p values for the correlation coefficients. Significant results are highlighted in bold

ASD autism spectrum disorder; BDI-II Beck Depression Inventory II (Beck et al., 1996; Hautzinger et al., 2006); β_group coefficient for the group parameter from the regression model; d Cohen’s d; MT macular thickness; MV macular volume; NT neurotypical adults; ONL outer nuclear layer; rho Spearman’s rho; SE standard error of the coefficient; SRS-2 Social Responsiveness Scale 2 (Constantino, 2012); WURS-k Wender Utah Rating Scale (Retz-Junginger et al., 2002)

Similarly, the reduction in the MT, MV and the ONL thickness was also observable in the ASD subsample without depressive symptoms (N = 18) when compared to NT, whereas the ONL volume was not significantly reduced.

Comparing the ASD subsample without the intake of psychiatric medication (N = 14) to the NT group, all previously detected reductions in the MT, MV and ONL thickness and volume were still observed.

The subsequent explorative analyses for the associations between the macular and the ONL thicknesses and volumes and the SRS-2 (Constantino, 2012) scores for the ASD subsamples are summarized in Table 4. With the exception of the MV in the ASD subsample without ADHD related symptoms in childhood, the statistically significant inverse associations between the SRS-2 (Constantino, 2012) scores and the macular and ONL thicknesses and volumes were observable in all ASD subsamples.

Region and Sector Analyses of the Macular and ONL Thicknesses Within the ETDRS Grid

Figure 3A, B illustrates the MT and ONL thickness data for the three foveal regions for both groups. Supplemental Table 1 summarizes the group coefficients of the regression models.

Group coefficients of the robust regression models revealed a significant reduction in the para- (β_group = − 46.14 µm (3.25%); p = 0.002 (*); d = − 0.83) and perifoveal (β_group = − 34.22 µm (2.78%); p = 0.009 (*); d = − 0.69) MT in ASD.

All three regions of the ONL were statistically significantly reduced in ASD compared to NT (fovea: β_group = − 6.68 µm (6.57%); p = 0.01 (*); d = − 0.68; parafovea: β_group = − 26.21 µm (8.11%); p = 0.002 (*); d = − 0.81; perifovea: β_group = − 20.15 µm (7.69%); p = 0.005 (*); d = − 0.75). The significance level was Benjamini-Hochberg (1995) adjusted according to the number of regression models (6 comparisons).

The subsequent sector analysis revealed, that almost all sectors of the ETDRS grid for the macular and ONL thickness were affected in ASD (Fig. 3C, D and Supplemental Table 1). Only the foveal and the superior-perifoveal sector of the MT as well as the superior-parafoveal sector of the ONL showed no significant thinning in ASD compared to NT. The number of regression models (18 comparisons) was used for Benjamini-Hochberg (1995) adjustment.

The most pronounced reductions in the MT of autistic adults were found within the parafoveal region in the temporal and nasal sectors (large effect; d >|0.8|). The most distinctive thinning in the ONL of autistic adults was observed in the temporal parafovea (large effect; d >|0.8|).

Discussion

Our study compared thicknesses and volumes of the macula and the different intraretinal layers between autistic adults and NT using OCT. We observed a moderate reduction in the total MT and MV as well as a severe reduction in the total ONL thickness and volume in ASD. The macular thinning was found in the para- and perifoveal region, while alterations in the ONL thickness were detected in all regions (fovea, peri- and parafovea).

In contrast to previous OCT investigations (Emberti Gialloreti et al., 2014; García-Medina et al., 2017), we found no alterations of the RNFL in autistic adults.

While we observed thinning of the MT and ONL in adults with ASD, a previous study by García-Medina et al. (2017) showed greater thickness of the total retina (equivalent to the MT) and the total inner retina (comprising the RNFL, GCL, IPL, INL) at the fovea as well as an elevated inferior pRNFL thickness in ASD. Additionally, the inferior pRNFL thickness was positively associated with the composite IQ of autistic adults (García-Medina et al., 2017).

The different observations may be due to the fact that the preceding study examined autistic children and adolescents (García-Medina et al., 2017), while we focused on adults. The retinal thickening in children (García-Medina et al., 2017), trends towards an elevated MT and pRNFL thickness in adolescents and young adults with ASD (Garcia-Medina et al., 2020) and the finding of retinal thinning in adults with ASD in our and a preceding study (Emberti Gialloreti et al., 2014) might complement observations from neuroimaging studies. While there is consensus on early brain overgrowth during infancy (Ecker et al., 2015; Hazlett et al., 2011; Prigge et al., 2021) followed by an arrested growth and normalization in brain volume from adolescence to late middle age (Courchesne et al., 2011; Ecker et al., 2015; Prigge et al., 2021), alterations in cerebral structures in adulthood in ASD are under debate. Although some studies pointed towards a reduced brain volume in autistic adults (Courchesne et al., 2011; Ecker et al., 2015), others reported normal brain (Denier et al., 2022; Riedel et al., 2014) and gray matter (Prigge et al., 2021) volumes as well as an unaltered cortical thickness in autistic adults with ASD (Maier et al., 2018). Likewise, we found no reductions in the pRNFL, RNFL, GCL, IPL, INL, OPL and PR + RPE, which were reported to be positively associated with the total brain, the total gray and white matter volumes (Mauschitz et al., 2022). The thickness of the ONL –comprising the cell bodies of the photoreceptors, representing the first step in the retinal afferent path– seemed not to be correlated with any of these cerebral structures (Mauschitz et al., 2022). The reasons for the retinal alterations observed in adults with ASD, however, have not yet been clarified or directly compared to brain imaging data. As potential underlying correlates, neuroinflammatory processes (Nakagawa & Chiba, 2016) or a modification in the programmed cell death (Wei et al., 2014) within the retina have been discussed.

It has to be stressed that assumptions with respect to the precise link between retinal and global neuronal network abnormalities in ASD remain speculative. One could speculate that the volume loss of the retinal ONL is due to migratory or other neurodevelopmental network perturbations that reflect synchronously occurring neurodevelopmental perturbations in isocortical networks.

Alternatively, the ONL abnormalities could reflect a shift in GABAergic and glutamatergic signaling in ASD, as postulated by the excitatory/inhibitory imbalance hypothesis (E/I imbalance hypothesis), given that both neurotransmitters also play a central role at a retinal level (Rubenstein & Merzenich, 2003; Tebartz van Elst et al., 2014). In this framework, the retina was examined in a prenatally exposed valproic acid autism mouse model in a previous study (Guimarães-Souza et al., 2019), because sensoric hypo-/hypersensitivity to visual stimuli is a well known phenomenon in ASD. The retina, as part of the CNS, mainly uses GABA and glutamate to modulate and transmit visual signals (Wu, 2010). Guimarães-Souza et al. (2019) detected reduced GABA expression and increased mGluR5 in the retinas of early adolescent mice prenatally exposed to valproic acid (Guimarães-Souza et al., 2019), a finding that relates well to the proposed E/I imbalance hypothesis of ASD (Rubenstein & Merzenich, 2003).

While we detected structural retinal alterations of the ONL and MT, we found no functional retinal changes in an ERG study in an overlapping sample of autistic adults (Friedel et al., 2022b). However, how and whether functional and structural retinal changes are associated and related to the E/I imbalance hypothesis needs to be further investigated in combined ophthalmologic and neuroimaging studies in the future.

We detected a significant inverse correlation between the severity of ASD-related symptoms and presence of social impairment, measured by the total SRS-2 score (Constantino, 2012), and the thickness and volume of the ONL. Based on these association, future longitudinal studies should investigate whether alterations in retinal layer thickness could represent a suitable biomarker for ASD. It remains to be clarified how the thickness of the ONL develops during the course of the disorder, and whether it might represent a state or a possible trait marker.

Limitations

The cross-sectional design of our study does not allow conclusions on whether the detected alterations in the ONL represent a state or a trait marker. The results require replication in a larger sample, however, the current study examined a comparable number of autistic adults using OCT as previous studies. Based on the psychometric assessments, autistic adults had significantly elevated symptoms of depression and ADHD in childhood when compared to NT, a potential source of bias. However, the reduction in the MT and ONL thickness and volume was also significant in the subsample of autistic adults without elevated scores of ADHD related symptoms in childhood. Likewise, the MT, MV and ONL thickness reduction was also detected in the ASD subgroup without depressive symptoms.

Although possible confounding effects of psychiatric medication cannot be ruled out, the analysis of the ASD subsample without psychiatric medication revealed, that all previously observed reductions in the MV, MT and ONL thickness and volume were also apparent in unmedicated autistic adults. Therefore, it is unlikely that the retinal thinning is due to a medication effect.

Conclusions

Retinal layer thicknesses and volumes in thirty-four autistic adults and thirty-one NT adults were investigated and compared with OCT. We detected a reduction of the total MT, MV as well as of the total ONL thickness and volume. Macular thinning was restricted to the para- and perifoveal region, whereas ONL thinning was observed in all regions (fovea, peri- and parafovea) in autistic adults.

Further studies are required to clarify whether these structural retinal alterations are already evident in early childhood or manifest during the course of the disease. To gain a more comprehensive picture of ASD, future investigations may evaluate how retinal and cerebral alterations are interconnected, whether the structural deficits of the retina are associated with atypical retinal functioning and how other parameters such as medication intake may play a role. It would be desirable to analyze a larger sample of autistic adults across different age spans and additionally include a larger cohort of medication naïve participants.

Acknowledgments

Not applicable.

Declarations

Competing interests

Evelyn B.N. Friedel: no conflict of interest, Ludger Tebartz van Elst: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics, Mirjam Schäfer: no conflict of interest, Simon Maier: no conflict of interest, Kimon Runge: no conflict of interest, Sebastian Küchlin: no conflict of interest, Michael Reich: no conflict of interest, Wolf A. Lagrèze: no conflict of interest, Jürgen Kornmeier: no conflict of interest, Dieter Ebert: no conflict of interest, Dominique Endres: no conflict of interest, Katharina Domschke: member of the ‘Steering Committee Neurosciences’, Janssen Pharmaceuticals, Inc., Kathrin Nickel: no conflict of interest.

Ethics Approval

The study was approved by the Ethics Committee of the University Medical Center Freiburg (Approval ID: 314/18). All participants gave written informed consent to participate in the study.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

vorige artikel Exploring Autistic College Students’ Perceptions and Management of Peer Stigma: An Interpretative Phenomenological Analysis

volgende artikel A Qualitative Study of Adults’ and Support Persons’ Experiences of Support After Autism Diagnosis

Onze productaanbevelingen

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijf je als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen jouw vak. Met het online abonnement heb je toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kun je op je gemak en wanneer het jou het beste uitkomt verdiepen in jouw vakgebied.

Meer informatie

BSL Academy Accare GGZ collective

Meer informatie

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 kb)

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425596CrossRef

Aytulun, A., Cruz-Herranz, A., Aktas, O., Balcer, L. J., Balk, L., Barboni, P., Blanco, A. A., Calabresi, P. A., Costello, F., Sanchez-Dalmau, B., DeBuc, D. C., Feltgen, N., Finger, R. P., Frederiksen, J. L., Frohman, E., Frohman, T., Garway-Heath, D., Gabilondo, I., Graves, J. S., … Albrecht, P. (2021). APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology, 97(2), 68–79. https://doi.org/10.1212/WNL.0000000000012125CrossRefPubMedPubMedCentral

Bach, M. (2007). The Freiburg visual acuity test—variability unchanged by post-hoc re-analysis. Graefe’s Archive for Clinical and Experimental Ophthalmology, 245(7), 965–971. https://doi.org/10.1007/s00417-006-0474-4CrossRefPubMed

Bagci, A. M., Shahidi, M., Ansari, R., Blair, M., Blair, N. P., & Zelkha, R. (2008). Thickness profiles of retinal layers by optical coherence tomography image segmentation. American Journal of Ophthalmology, 146(5), 679-687.e1. https://doi.org/10.1016/j.ajo.2008.06.010CrossRefPubMedPubMedCentral

Baron-Cohen, S., & Wheelwright, S. (2004). The empathy quotient: An investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. Journal of Autism and Developmental Disorders, 34(2), 163–175. https://doi.org/10.1023/B:JADD.0000022607.19833.00CrossRefPubMed

Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. https://doi.org/10.1023/a:1005653411471CrossRefPubMed

Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. (1996). Comparison of beck depression inventories -IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67(3), 588–597. https://doi.org/10.1207/s15327752jpa6703_13CrossRefPubMed

Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (methodological), 57(1), 289–3006.MathSciNetCrossRef

Ben-Shachar, M. S., Lüdecke, D., & Makowski, D. (2020). Effectsize: Estimation of effect size indices and standardized parameters. Journal of Open Source Software, 5(56), 2815. https://doi.org/10.21105/joss.02815ADSCrossRef

Best, D. J., & Roberts, D. E. (1975). Algorithm AS 89: The upper tail probabilities of Spearman’s Rho. Applied Statistics, 24(3), 377. https://doi.org/10.2307/2347111CrossRef

Bigler, E. D., Abildskov, T. J., Petrie, J. A., Johnson, M., Lange, N., Chipman, J., Lu, J., McMahon, W., & Lainhart, J. E. (2010). Volumetric and voxel-based morphometry findings in autism subjects with and without macrocephaly. Developmental Neuropsychology, 35(3), 278–295. https://doi.org/10.1080/87565641003696817CrossRefPubMedPubMedCentral

Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., Lad, E. M., Mok, V. C. T., & Cheung, C. Y. (2019). Spectral-Domain OCT measurements in Alzheimer’s disease: A systematic review and meta-analysis. Ophthalmology, 126(4), 497–510. https://doi.org/10.1016/j.ophtha.2018.08.009CrossRefPubMed

Chew, E. Y. (1996). Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early treatment diabetic retinopathy study (ETDRS) report 22. Archives of Ophthalmology, 114(9), 1079. https://doi.org/10.1001/archopht.1996.01100140281004CrossRefPubMed

Chua, S. Y. L., Lascaratos, G., Atan, D., Zhang, B., Reisman, C., Khaw, P. T., Smith, S. M., Matthews, P. M., Petzold, A., Strouthidis, N. G., Foster, P. J., Khawaja, A. P., Patel, P. J., The UK Biobank Eye, Vision Consortium. (2021). Relationships between retinal layer thickness and brain volumes in the UK Biobank cohort. European Journal of Neurology, 28(5), 1490–1498. https://doi.org/10.1111/ene.14706CrossRefPubMedPubMedCentral

Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.CrossRefPubMed

Conciatori, M., Stodgell, C. J., Hyman, S. L., O’Bara, M., Militerni, R., Bravaccio, C., Trillo, S., Montecchi, F., Schneider, C., Melmed, R., Elia, M., Crawford, L., Spence, S. J., Muscarella, L., Guarnieri, V., D’Agruma, L., Quattrone, A., Zelante, L., Rabinowitz, D., … Persico, A. M. (2004). Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biological Psychiatry, 55(4), 413–419. https://doi.org/10.1016/j.biopsych.2003.10.005CrossRefPubMed

Constantino, J. N., Gruber C.P. (2012). Social responsiveness scale - Second Edition (SRS-2). Torrance, CA. Western Psychological Services.

Courchesne, E., Campbell, K., & Solso, S. (2011). Brain growth across the life span in autism: Age-specific changes in anatomical pathology. Brain Research, 1380, 138–145. https://doi.org/10.1016/j.brainres.2010.09.101CrossRefPubMed

Cruz-Herranz, A., Balk, L. J., Oberwahrenbrock, T., Saidha, S., Martinez-Lapiscina, E. H., Lagreze, W. A., Schuman, J. S., Villoslada, P., Calabresi, P., Balcer, L., Petzold, A., Green, A. J., Paul, F., Brandt, A. U., & Albrecht, P. (2016). The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology, 86(24), 2303–2309. https://doi.org/10.1212/WNL.0000000000002774CrossRefPubMedPubMedCentral

Denier, N., Steinberg, G., van Elst, L. T., & Bracht, T. (2022). The role of head circumference and cerebral volumes to phenotype male adults with autism spectrum disorder. Brain and Behavior. https://doi.org/10.1002/brb3.2460CrossRefPubMedPubMedCentral

Derogatis, L. R., & Savitz, K. L. (1999). The SCL-90-R, Brief symptom inventory, and matching clinical rating scales. The use of psychological testing for treatment planning and outcomes assessment (2nd ed., pp. 679–724). Lawrence Erlbaum Associates Publishers.

Ecker, C., Bookheimer, S. Y., & Murphy, D. G. M. (2015). Neuroimaging in autism spectrum disorder: Brain structure and function across the lifespan. The Lancet Neurology, 14(11), 1121–1134. https://doi.org/10.1016/S1474-4422(15)00050-2CrossRefPubMed

Emberti Gialloreti, L., Pardini, M., Benassi, F., Marciano, S., Amore, M., Mutolo, M. G., Porfirio, M. C., & Curatolo, P. (2014). Reduction in retinal nerve fiber layer thickness in young adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 44(4), 873–882. https://doi.org/10.1007/s10803-013-1939-zCrossRefPubMed

Friedel, E. B. N., Hahn, H.-T., Maier, S., Küchlin, S., Reich, M., Runge, K., Bach, M., Heinrich, S. P., Kornmeier, J., Endres, D., Ebert, D., Domschke, K., Tebartz van Elst, L., & Nickel, K. (2022a). Structural and functional retinal alterations in patients with paranoid schizophrenia. Translational Psychiatry, 12(1), 402. https://doi.org/10.1038/s41398-022-02167-7CrossRefPubMedPubMedCentral

Friedel, E. B. N., Schäfer, M., Endres, D., Maier, S., Runge, K., Bach, M., Heinrich, S. P., Ebert, D., Domschke, K., Tebartz van Elst, L., & Nickel, K. (2022b). Electroretinography in adults with high-functioning autism spectrum disorder. Autism Research, 322, 111464. https://doi.org/10.1002/aur.2823CrossRef

Fydrich, T., Renneberg, B., Schmitz, B., & Wittchen, H.-U. (1997). SKID II. Strukturiertes Klinisches Interview für DSM-IV, Achse II: Persönlichkeitsstörungen. Interviewheft. Eine deutschspeachige, erw. Bearb. d. amerikanischen Originalversion d. SKID-II von: M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams, L. Benjamin, Göttingen, Hogrefe.

García-Medina, J. J., García-Piñero, M., del-Río-Vellosillo, M., Fares-Valdivia, J., Ragel-Hernández, A. B., Martínez-Saura, S., Cárcel-López, M. D., Zanon-Moreno, V., Pinazo-Duran, M. D., & Villegas-Pérez, M. P. (2017). Comparison of foveal, macular, and peripapillary intraretinal thicknesses between autism spectrum disorder and neurotypical subjects. Investigative Opthalmology & Visual Science, 58(13), 5819. https://doi.org/10.1167/iovs.17-22238CrossRef

Garcia-Medina, J. J., Rubio-Velazquez, E., Lopez-Bernal, M. D., Parraga-Muñoz, D., Perez-Martinez, A., Pinazo-Duran, M. D., & Del-Rio-Vellosillo, M. (2020). Optical coherence tomography angiography of macula and optic nerve in autism spectrum Disorder: A pilot study. Journal of Clinical Medicine, 9(10), E3123. https://doi.org/10.3390/jcm9103123CrossRef

Garway-Heath, D. F., Poinoosawmy, D., Fitzke, F. W., & Hitchings, R. A. (2000). Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology, 107(10), 1809–1815. https://doi.org/10.1016/S0161-6420(00)00284-0CrossRefPubMed

Gokhale, S. G., & Gokhale, S. (2007). Genetic and evolutional mechanisms explain associated malformations—A “G-E-M” concept. Medical Hypotheses, 69(4), 879–883. https://doi.org/10.1016/j.mehy.2006.12.057CrossRefPubMed

Guimarães-Souza, E. M., Joselevitch, C., Britto, L. R. G., & Chiavegatto, S. (2019). Retinal alterations in a pre-clinical model of an autism spectrum disorder. Molecular Autism, 10(1), 19. https://doi.org/10.1186/s13229-019-0270-8CrossRefPubMedPubMedCentral

Hashem, S., Nisar, S., Bhat, A. A., Yadav, S. K., Azeem, M. W., Bagga, P., Fakhro, K., Reddy, R., Frenneaux, M. P., & Haris, M. (2020). Genetics of structural and functional brain changes in autism spectrum disorder. Translational Psychiatry, 10(1), 229. https://doi.org/10.1038/s41398-020-00921-3CrossRefPubMedPubMedCentral

Hautzinger, M., Keller, F., & Kühner, C. (2006). Beck Depressions-Inventar: BDI II. Revision. Deutsche Bearbeitung von Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory–II (BDI–II). San Antonio, TX: Harcourt Assessment Inc (Revision). Harcourt Test Services.

Hazlett, H. C., Poe, M. D., Gerig, G., Styner, M., Chappell, C., Smith, R. G., Vachet, C., & Piven, J. (2011). Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Archives of General Psychiatry, 68(5), 467. https://doi.org/10.1001/archgenpsychiatry.2011.39CrossRefPubMedPubMedCentral

Henry, L., & Wickham, H. (2020). purrr: Functional Programming Tools. https://CRAN.R-project.org/package=purrr

Hollander, M., & Wolfe, D. A. (1973). Nonparametric statistical methods. Wiley.

Huang, D., Swanson, E. A., Lin, C. P., Schuman, J. S., Stinson, W. G., Chang, W., Hee, M. R., Flotte, T., Gregory, K., Puliafito, C. A., & Fujimoto, J. G. (1991). Optical coherence tomography. Science, 254(5035), 1178–1181. https://doi.org/10.1126/science.1957169ADSCrossRefPubMedPubMedCentral

Jindahra, P., Hedges, T. R., Mendoza-Santiesteban, C. E., & Plant, G. T. (2010). Optical coherence tomography of the retina: Applications in neurology. Current Opinion in Neurology, 23(1), 16–23. https://doi.org/10.1097/WCO.0b013e328334e99bCrossRefPubMed

Kassambara, A. (2021). rstatix: Pipe-friendly framework for basic statistical tests. https://CRAN.R-project.org/package=rstatix

Koller, M., & Stahel, W. A. (2011). Sharpening Wald-type inference in robust regression for small samples. Computational Statistics & Data Analysis, 55(8), 2504–2515. https://doi.org/10.1016/j.csda.2011.02.014MathSciNetCrossRef

Lehrl, S., Triebig, G., & Fischer, B. (1995). Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurologica Scandinavica, 91(5), 335–345.CrossRefPubMed

Little, J.-A. (2018). Vision in children with autism spectrum disorder: A critical review: Vision in children with autism. Clinical and Experimental Optometry, 101(4), 504–513. https://doi.org/10.1111/cxo.12651CrossRefPubMed

Lord, C., Elsabbagh, M., Baird, G., & Veenstra-Vanderweele, J. (2018). Autism spectrum disorder. The Lancet, 392(10146), 508–520. https://doi.org/10.1016/S0140-6736(18)31129-2CrossRef

Maechler, M., Rousseeuw, P., Croux, C., Todorov, V., Ruckstuhl, A., Salibian-Barrera, M., Verbeke, T., Koller, M., Conceicao, E. L. T., & Palma, M. A. di. (2021). robustbase: Basic Robust Statistics. http://robustbase.r-forge.r-project.org/

Maier, S., van Elst, L. T., Perlov, E., Düppers, A. L., Nickel, K., Fangmeier, T., Endres, D., & Riedel, A. (2018). Cortical properties of adults with autism spectrum disorder and an IQ>100. Psychiatry Research: Neuroimaging, 279, 8–13. https://doi.org/10.1016/j.pscychresns.2018.06.013CrossRefPubMed

Mauschitz, M. M., Lohner, V., Koch, A., Stöcker, T., Reuter, M., Holz, F. G., Finger, R. P., & Breteler, M. M. B. (2022). Retinal layer assessments as potential biomarkers for brain atrophy in the Rhineland Study. Scientific Reports, 12(1), 2757. https://doi.org/10.1038/s41598-022-06821-4ADSCrossRefPubMedPubMedCentral

Mutlu, U., Bonnemaijer, P. W. M., Ikram, M. A., Colijn, J. M., Cremers, L. G. M., Buitendijk, G. H. S., Vingerling, J. R., Niessen, W. J., Vernooij, M. W., Klaver, C. C. W., & Ikram, M. K. (2017). Retinal neurodegeneration and brain MRI markers: The Rotterdam study. Neurobiology of Aging, 60, 183–191. https://doi.org/10.1016/j.neurobiolaging.2017.09.003CrossRefPubMed

Mutlu, U., Colijn, J. M., Ikram, M. A., Bonnemaijer, P. W. M., Licher, S., Wolters, F. J., Tiemeier, H., Koudstaal, P. J., Klaver, C. C. W., & Ikram, M. K. (2018). Association of retinal neurodegeneration on optical coherence tomography with dementia: A population-based study. JAMA Neurology, 75(10), 1256. https://doi.org/10.1001/jamaneurol.2018.1563CrossRefPubMedPubMedCentral

Nakagawa, Y., & Chiba, K. (2016). Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia. Journal of Pharmacology and Experimental Therapeutics, 358(3), 504–515. https://doi.org/10.1124/jpet.116.234476CrossRefPubMed

Nguyen, C. T. O., Hui, F., Charng, J., Velaedan, S., van Koeverden, A. K., Lim, J. K. H., He, Z., Wong, V. H. Y., Vingrys, A. J., Bui, B. V., & Ivarsson, M. (2017). Retinal biomarkers provide “insight” into cortical pharmacology and disease. Pharmacology & Therapeutics, 175, 151–177. https://doi.org/10.1016/j.pharmthera.2017.02.009CrossRef

Noval, S., Contreras, I., Muñoz, S., Oreja-Guevara, C., Manzano, B., & Rebolleda, G. (2011). Optical coherence tomography in multiple sclerosis and neuromyelitis optica: An update. Multiple Sclerosis International, 2011, e472790. https://doi.org/10.1155/2011/472790CrossRef

Pardo, C. A., & Eberhart, C. G. (2007). The neurobiology of autism. Brain Pathology, 17(4), 434–447. https://doi.org/10.1111/j.1750-3639.2007.00102.xCrossRefPubMedPubMedCentral

Podoleanu, AGh. (2012). Optical coherence tomography. Journal of Microscopy, 247(3), 209–219. https://doi.org/10.1111/j.1365-2818.2012.03619.xCrossRefPubMedPubMedCentral

Prigge, M. B. D., Lange, N., Bigler, E. D., King, J. B., Dean, D. C., Adluru, N., Alexander, A. L., Lainhart, J. E., & Zielinski, B. A. (2021). A 16-year study of longitudinal volumetric brain development in males with autism. NeuroImage, 236, 118067. https://doi.org/10.1016/j.neuroimage.2021.118067CrossRefPubMed

R Core Team. (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/

Retz-Junginger, P., Retz, W., Blocher, D., Weijers, H.-G., Trott, G.-E., Wender, P. H., & Rössler, M. (2002). Wender Utah Rating Scale (WURS-k) Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Der Nervenarzt, 73(9), 830–838. https://doi.org/10.1007/s00115-001-1215-xCrossRefPubMed

Riedel, A., Maier, S., Ulbrich, M., Biscaldi, M., Ebert, D., Fangmeier, T., Perlov, E., & van Elst, L. T. (2014). No significant brain volume decreases or increases in adults with high-functioning autism spectrum disorder and above average intelligence: A voxel-based morphometric study. Psychiatry Research: Neuroimaging, 223(2), 67–74. https://doi.org/10.1016/j.pscychresns.2014.05.013CrossRef

Robinson, D., Hayes, A., & Couch, S. (2022). broom: Convert Statistical Objects into Tidy Tibbles. https://CRAN.R-project.org/package=broom

RStudio Team. (2022). RStudio: Integrated development environment for R. RStudio, PBC. http://www.rstudio.com/

Rubenstein, J. L. R., & Merzenich, M. M. (2003). Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior, 2(5), 255–267. https://doi.org/10.1034/j.1601-183X.2003.00037.xCrossRefPubMed

Schönfeldt-Lecuona, C., Kregel, T., Schmidt, A., Pinkhardt, E. H., Lauda, F., Kassubek, J., Connemann, B. J., Freudenmann, R. W., & Gahr, M. (2015). From imaging the brain to imaging the retina: Optical coherence tomography (OCT) in schizophrenia. Schizophrenia Bulletin, 42(1), 9–14. https://doi.org/10.1093/schbul/sbv073CrossRefPubMedPubMedCentral

Silverstein, S. M., Demmin, D. L., Schallek, J. B., & Fradkin, S. I. (2020). Measures of retinal structure and function as biomarkers in neurology and psychiatry. Biomarkers in Neuropsychiatry. https://doi.org/10.1016/j.bionps.2020.100018CrossRef

Tebartz van Elst, L., Maier, S., Fangmeier, T., Endres, D., Mueller, G. T., Nickel, K., Ebert, D., Lange, T., Hennig, J., Biscaldi, M., Riedel, A., & Perlov, E. (2014). Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: Evidence in support of the excitatory/inhibitory imbalance hypothesis. Molecular Psychiatry, 19(12), 1314–1325. https://doi.org/10.1038/mp.2014.62CrossRefPubMed

Tebartz van Elst, L. (Ed.). (2021). Autismus-Spektrum-Störungen im Erwachsenenalter (3., aktualisierte und erweiterte Auflage). Berlin, MWV Medizinisch Wissenschaftliche Verlagsgesellschaft.

Wei, H., Alberts, I., & Li, X. (2014). The apoptotic perspective of autism. International Journal of Developmental Neuroscience: THe Official Journal of the International Society for Developmental Neuroscience, 36, 13–18. https://doi.org/10.1016/j.ijdevneu.2014.04.004CrossRefPubMed

Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. https://ggplot2.tidyverse.org

Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L. D., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., Kuhn, M., Pedersen, T. L., Miller, E., Bache, S. M., Müller, K., Ooms, J., Robinson, D., Seidel, D. P., Spinu, V., … Yutani, H. (2019). Welcome to the tidyverse. Journal of Open Source Software, 4(43), 1686. https://doi.org/10.21105/joss.01686ADSCrossRef

Wittchen, H.-U., Wunderlich, U., Gruschwitz, S., & Zaudig, M. (1997). SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Göttingen, Hogrefe.

World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191. https://doi.org/10.1001/jama.2013.281053CrossRef

Wu, S. M. (2010). Synaptic organization of the vertebrate retina: General principles and species-specific variations: The Friedenwald lecture. Investigative Ophthalmology & Visual Science, 51(3), 1263–1274. https://doi.org/10.1167/iovs.09-4396CrossRef

Titel: Retinal Thinning in Adults with Autism Spectrum Disorder
Auteurs: Evelyn B. N. Friedel
Ludger Tebartz van Elst
Mirjam Schäfer
Simon Maier
Kimon Runge
Sebastian Küchlin
Michael Reich
Wolf A. Lagrèze
Jürgen Kornmeier
Dieter Ebert
Dominique Endres
Katharina Domschke
Kathrin Nickel
Publicatiedatum: 23-12-2022
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 3/2024
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-022-05882-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Supplementary Information

Publisher's Note

Aims of the Study

Methods

Participants

Optical Coherence Tomography (OCT)

Statistical Analysis

Results

Participants

Peripapillary RNFL (pRNFL) Thickness (Optic Nerve Head – Radial Circle Scan)

Circumfoveal Retinal Layer Thicknesses and Volumes (Posterior Pole Horizontal Scan)

Total ETDRS Thickness and Volume of the Macula and the Intraretinal Layers

Associations Between Retinal Thinning in Autistic Adults and the Severity of ASD Symptoms

Subsamples of Autistic Adults Without Comorbid (ADHD Symptoms in Childhood or Depressive) Symptoms or the Intake of Medication

Region and Sector Analyses of the Macular and ONL Thicknesses Within the ETDRS Grid

Discussion

Limitations

Conclusions

Acknowledgments

Declarations

Competing interests

Ethics Approval

Publisher's Note

Deel dit onderdeel of sectie (kopieer de link)

Onze productaanbevelingen

BSL Psychologie Totaal

BSL Academy Accare GGZ collective

Supplementary Information

Andere artikelen Uitgave 3/2024

Male and Female Toddlers with DSM-5 Autism Spectrum Disorder have Similar Developmental Profiles and Core Autism Symptoms

Social-Motor Coordination Between Peers: Joint Action Developmental Trajectories in ASD and TD

Factors Impacting Parental Quality of Life in Preschool Children on the Autism Spectrum

Extending the Usefulness of the Brief Observation of Social Communication Change (BOSCC): Validating the Phrase Speech and Young Fluent Version

A Systematic Review of Family Functioning in Families of Children on the Autism Spectrum

Differences in Praxis Errors in Autism Spectrum Disorder Compared to Developmental Coordination Disorder